Oklahoma 2026 Regular Session

Oklahoma Senate Bill SB1646

Introduced
2/2/26  
Refer
2/3/26  
Report Pass
2/26/26  

Caption

Health insurance; requiring coverage of medically necessary treatment of mental health and substance use disorders; prohibiting certain limitations. Effective date.

Impact

The legislation is expected to close gaps in mental health and substance use disorder treatment by prohibiting health benefit plans from limiting coverage to short-term treatment. Instead, they are required to provide comprehensive care that addresses chronic and pervasive issues. The bill also emphasizes the importance of using evidence-based criteria for determining the medical necessity of treatments, thus enhancing accountability among insurance providers regarding their coverage decisions.

Summary

Senate Bill 1646 aims to enhance coverage for mental health and substance use disorders under health benefit plans in Oklahoma. The bill mandates that all health benefit plans that provide hospital, medical, or surgical coverage must also provide coverage for medically necessary treatments related to mental health and substance use disorders. It specifies that these services must align with guidelines from recognized clinical specialty associations, thereby ensuring a standardized level of care across different insurance providers.

Sentiment

The sentiment surrounding SB 1646 appears generally supportive among mental health advocates and professionals who believe that improved insurance coverage will lead to better health outcomes for individuals with mental health issues. However, some concerns may arise regarding how insurance companies will implement these changes, particularly in terms of compliance with the new standards and the potential for increased costs.

Contention

Notable points of contention include the specifics of utilization review processes, which must conform to the established standards of care without imposing additional, restrictive criteria. This aspect of the bill is critically reviewed to ensure that insurance companies cannot deny necessary treatments unjustly. Legislative discussions likely held debates on the bill’s potential administrative burden on health providers and the extent of enforcement by the Insurance Commissioner in cases of policy violations.

Companion Bills

No companion bills found.

Previously Filed As

OK HB2049

Medicaid parity; coverage; mental health and substance use disorders; contract compliance; noncompliance reviews; Oklahoma Health Care Authority; complaints; publication of reports; effective date.

OK SB1019

Health insurance; requiring certain coverage. Effective date.

OK SB1047

Health insurance; requiring reimbursement for certain health care services. Effective date.

OK SB109

Health insurance; requiring coverage of certain genetic testing and cancer imaging; providing exclusions. Effective date.

OK SB740

Mental health; modifying certain definitions. Effective date.

OK SB438

Health insurance; methods of payments to providers; requiring notice of certain fee. Effective date.

OK SB670

Health care providers; requiring certain continuing education; requiring specified mental health screening. Effective date.

OK HB2797

Health Care Authority; prohibiting use of certain methodology; audits; fraud reporting; requiring joint collaboration between Department of Mental Health and Substance Abuse Services and Department of Human Services; duties; emergency.

OK HB2248

Mental health; rural mental health and treatment diversion pilot programs; purpose; Department of Mental Health and Substance Abuse Services; contracts; promulgation of rules; effective date.

OK SB176

Health benefit plans; requiring coverage for certain prescription. Effective date.

Similar Bills

US HB830

SAFE Act Save Americans from the Fentanyl Emergency Act

MA H2227

Replacing archaic and stigmatizing language for substance use

MI HB4948

Controlled substances: other; sentencing guidelines for retail sale of products containing ephedrine or pseudoephedrine; modify. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4947'25

MI HB4167

Criminal procedure: sentencing guidelines; sentencing guidelines for illicit use of xylazine; provide for. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m).

NJ S829

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

NJ A1617

"CJ's Law"; Criminalizes manufacture, sale, and possession of substances containing kratom.

MI HB4256

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver certain controlled substances; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: HB 4255'25

MI SB0431

Criminal procedure: sentencing guidelines; sentencing guidelines for delivering, manufacturing, or possessing with intent to deliver heroin or fentanyl; amend. Amends sec. 13m, ch. XVII of 1927 PA 175 (MCL 777.13m). TIE BAR WITH: SB 0430'25